MARIAN MARRERO: Open Payments
NPI 1003503087 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,312 in 138 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $470 · 2025 $3,312
Food & beverage: $3,047Education: $265
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $608 |
| Actelion Pharmaceuticals US, Inc. | 14 | $492 |
| GENZYME CORPORATION | 12 | $416 |
| Regeneron Healthcare Solutions, Inc. | 16 | $273 |
| GlaxoSmithKline, LLC. | 18 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $186 |
| Verona Pharma, Inc. | 6 | $148 |
| SANOFI-AVENTIS U.S. LLC | 2 | $147 |
| Axsome Therapeutics, Inc. | 10 | $143 |
| Viatris Specialty LLC | 4 | $76 |
Products named: DUPIXENT, UPTRAVI, OPSUMIT, FASENRA, GLASSIA, TEZSPIRE, NUCALA, Ohtuvayre.
Industry payments across GA — which companies pay providers there.
